Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 CAD | -2.12% | +2.78% | -13.55% |
Sales 2024 * | 120M 87.5M | Sales 2025 * | 128M 93.51M | Capitalization | 85.06M 62.1M |
---|---|---|---|---|---|
Net income 2024 * | -6M -4.38M | Net income 2025 * | -13M -9.49M | EV / Sales 2024 * | 0.71 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.66 x |
P/E ratio 2024 * |
-11.7
x | P/E ratio 2025 * |
-7.73
x | Employees | 103 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.59% |
Latest transcript on Theratechnologies Inc.
1 day | -2.12% | ||
1 week | +2.78% | ||
Current month | -17.04% | ||
1 month | +6.94% | ||
3 months | -6.09% | ||
6 months | +9.47% | ||
Current year | -13.55% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Lévesque
CEO | Chief Executive Officer | 60 | 20-04-05 |
Philippe Dubuc
DFI | Director of Finance/CFO | 57 | 16-02-23 |
Chief Tech/Sci/R&D Officer | 61 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Molson
BRD | Director/Board Member | 56 | 20-10-15 |
Frank Holler
BRD | Director/Board Member | 67 | 21-06-22 |
Director/Board Member | 80 | 06-02-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1.85 | -2.12% | 16,019 |
24-04-23 | 1.89 | +2.16% | 5,402 |
24-04-22 | 1.85 | +2.21% | 5,600 |
24-04-19 | 1.81 | 0.00% | 7,876 |
24-04-18 | 1.81 | +0.56% | 4,800 |
Delayed Quote Toronto S.E., April 24, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.55% | 63.57M | |
-2.86% | 87.37B | |
+3.95% | 41.01B | |
-21.94% | 28.08B | |
+53.11% | 24.72B | |
-5.41% | 17.47B | |
-44.23% | 11.69B | |
-17.60% | 11.6B | |
-13.96% | 11.56B | |
-0.22% | 8.44B |
- Stock Market
- Equities
- TH Stock